
    
      A Phase 1, open-labeled, single-dose, one-sequence, one-period, 3-part study to investigate
      the absorption, metabolism, excretion, absolute bioavailability, and immunogenicity of GX-I7
      in healthy volunteers To show ABA and Mass balance of GX-I7
    
  